Volume | 725,532 |
|
|||||
News | - | ||||||
Day High | 14.07 | Low High |
|||||
Day Low | 13.19 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Oric Pharmaceuticals Inc | ORIC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
13.52 | 13.19 | 14.07 | 13.75 | 13.465 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
6,244 | 725,532 | $ 13.59 | $ 9,857,723 | - | 4.69 - 16.65 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:37:17 | 30 | $ 14.00 | USD |
Oric Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
924.4M | 67.38M | - | 0 | -89.12M | -1.32 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Oric Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ORIC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.16 | 15.35 | 13.17 | 13.73 | 409,520 | -1.41 | -9.30% |
1 Month | 12.20 | 16.65 | 11.86 | 14.39 | 797,423 | 1.55 | 12.70% |
3 Months | 9.09 | 16.65 | 7.85 | 12.38 | 576,654 | 4.66 | 51.27% |
6 Months | 6.42 | 16.65 | 5.27 | 9.86 | 505,625 | 7.33 | 114.17% |
1 Year | 4.96 | 16.65 | 4.69 | 8.80 | 413,627 | 8.79 | 177.22% |
3 Years | 23.40 | 26.70 | 2.36 | 8.57 | 382,676 | -9.65 | -41.24% |
5 Years | 26.00 | 40.81 | 2.36 | 12.10 | 348,730 | -12.25 | -47.12% |
Oric Pharmaceuticals Description
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533. |